Why I Chose the Name 'Discreet Ketamine'

People ask about the name. They hear "Discreet Ketamine" and they want to know the story. So here it is.

The idea started with a conversation between myself and my brother. We were talking about ketamine therapy -- the research behind it, the patients it was helping, and the gap between how effective the treatment is and how few people actually pursue it. He identified something that I, as a physician, had been seeing from the clinical side but had not fully articulated: the barrier is not skepticism about whether ketamine works. For many people, the barrier is discomfort with how treatment is delivered.

He put it simply: "Wouldn't it be great if the service just came to you? Something truly discreet?"

That word stuck with me. Discreet. It captured exactly the problem I wanted to solve.

The Gap Between Evidence and Access

The clinical evidence for ketamine in treatment-resistant depression, anxiety, and PTSD is strong and growing. But evidence alone does not get patients into treatment. I was seeing a pattern: people who had read the research, who had tried multiple antidepressants without adequate relief, who understood that ketamine might help -- but who could not bring themselves to walk into a clinic. For a deeper look at how ketamine compares to traditional options, see our article on ketamine vs. antidepressants.

The reasons varied, but a theme emerged. A healthcare worker in a small town did not want to be seen entering a ketamine clinic by a colleague or a patient. An executive worried that word would get back to his board. A mother did not want to explain to other parents at school pickup where she had been. A veteran felt that seeking mental health treatment conflicted with an identity he had built around self-reliance.

These are not trivial concerns. They are real, practical, human obstacles that prevent people from getting care they need.

Discreet Does Not Mean Ashamed

I want to be direct about this: choosing privacy is not the same as hiding. There is nothing shameful about treating depression, anxiety, PTSD, or chronic pain. Seeking help is not a weakness -- it is a decision that takes clarity and courage.

The fact is that mental health treatment still carries social weight in many communities and professions. Until that changes fully, patients deserve a treatment model that respects their preference for privacy without requiring them to justify it.

The name "Discreet Ketamine" is not an endorsement of stigma. It is a recognition that stigma still exists, and a promise that we will not force our patients to deal with it as a condition of getting help.

What "Discreet" Looks Like in Practice

At Discreet Ketamine, discretion is not just a brand value -- it is embedded in how we deliver care.

Your initial consultation with Dr. Ben Soffer, a board-certified internist, happens via secure telehealth. No waiting room. No check-in desk. No clipboard with your name on it.

Your medication arrives at your home by mail in standard packaging. Your treatment sessions happen in your own space, on your own schedule, with a peer supervisor you choose and trust.

Follow-up care, dose adjustments, and integration support all happen through our telehealth platform. There is no clinic to visit, no parking lot where someone might recognize your car, no sign-in sheet.

This is what at-home ketamine therapy looks like. It is professional, it is clinically rigorous, and it is private. For a full overview of our approach, see our guide on at-home ketamine therapy.

A Name That Keeps Its Promise

Every business name is a promise. Ours promises that you can access effective, physician-supervised ketamine treatment for depression, anxiety, PTSD, and chronic pain without sacrificing your privacy.

We serve patients in Florida and New Jersey, with treatment starting at $250/month. If that promise sounds like what you have been looking for, check your eligibility to get started.

Disclaimer: Compounded ketamine for anxiety, depression, PTSD, and chronic pain is not FDA approved.